Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China

Gynecologic Oncology

Volumn 101, Issue 1, 2006, Pages 92-96

  Li, Yan ^a   Jin, Xia ^a   Kang, Shan ^a   Wang, Ying ^a   Du, Hui ^a   Zhang, Jianhui ^a   Guo, Wei ^a   Wang, Na ^a   Fang, Shumei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Epithelium ovarian cancer; Matrix metalloproteinase 1, 3, 7, 9; Polymerase chain reaction; Restriction fragment length polymorphism; Single nucleotide polymorphism

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; STROMELYSIN;

ADULT; AGED; ALLELISM; ARTICLE; CANCER CYTODIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHINA; EPITHELIAL CELLS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISOENZYMES; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 33644538606     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.058     Document Type: Article

References (48)

1. Y. Chen, and B. Wu The epidemiologic study of ovarian cancer Prog. Obstet. Gynecol. 2 1991 30
2. Z. Cao Gynecologic Oncology 814 1998 Beijing Publisher 857
3. F. Stenbeck, and V.-M. Wasenius Basement membrane structures in tumors of the ovary Eur. J. Obstet. Gynecol. Reprod. Biol. 20 1985 357 371
4. R. Timpl, and M. Dziadek Structure, development, and molecular pathology of basement membranes Int. Rev. Exp. Pathol. 29 1986 1 112
5. D.H. Yang, E.R. Smith, C. Cohen, H. Wu, C. Patriotis, and A.K. Godwin Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity Cancer (Philadelphia) 94 2002 2380 2392
6. F.Q. Wang, J. So, S. Reierstad, and D.A. Fishman Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase Int. J. Cancer 10 2005 19 31
7. S. Ozalp, H.M. Tanir, O.T. Yalcin, S. Kabukcuoglu, U. Oner, and M. Ueay Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors Eur. J. Gynaecol. Oncol. 24 2003 417 420
8. P. Behrens, M. Rothe, A. Florn, A. Wellmann, and N. Wernert Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression Int. J. Mol. Med. 8 2001 149 154
9. B. Davidson, I. Goldberg, A. Berner, J.M. Nesland, V. Givant-Horwitz, and M. Bryne Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions Am. J. Clin. Pathol. 115 2001 517 524
10. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev., Cancer 2 2002 161 174
11. S. Ye Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases Matrix Biol. 19 2000 623 629
12. T. Nojiri, H. Morita, Y. Imai, K. Maemura, M. Ohno, and K. Ogasawara Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese Int. J. Cardiol. 92 2003 181 186
13. D.L. Mattey, N.B. Nixon, P.T. Dawes, W.E. Ollier, and A.H. Hajeer Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis Genes Immun. 5 2004 47 49
14. N. Fiotti, R. Zivadinov, N. Altamura, D. Nasuelli, A. Bratina, and M.A. Tommasi MMP-9 microsatellite polymorphism and multiple sclerosis J. Neuroimmunol. 152 2004 147 153
15. J. Zhang, X. Jin, S. Fang, Y. Li, R. Wang, and W. Guo The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastases in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma Carcinogenesis 25 2004 2519 2524
16. G. Liang, W. Tan, L. Zhang, and D. Lin Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer Cancer Res. 62 2002 6430 6433
17. J.L. Rutter, T.I. Mitchell, G. Buttice, J. Meyers, J.F. Gusella, and L.J. Ozelius A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription Cancer Res. 58 1998 5321 5325
18. S. Ye, G.F. Watts, S. Mandalia, S.E. Humphries, and A.M. Henney Preliminary report: genetic variation in the human stromelys in promoter is associated with progression of coronary atherosclerosis J. Br. Heart 73 1995 209 215
19. S. Ye, P. Eriksson, A. Hamsten, M. Kurkinen, S.E. Humphries, and A.M. Henney Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysis-1 promoter which results in reduced gene expression J. Biol. Chem. 271 1996 13055 13060
20. S. Jormsjo, C. Whatling, D.H. Walter, A.M. Zeiher, A. Hamsten, and P. Eriksson Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients Arterioscler. Thromb. Vasc. Biol. 21 2001 1834 1839
21. B. Zhang, S. Ye, S.M. Herrmann, P. Eriksson, M. de Maat, and A. Evans Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis Circulation 99 1999 1788 1794
22. Y. Zhu, M.R. Spitz, L. Lei, G.B. Mills, and X. Wu A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer the susceptibility Cancer Res. 61 2001 7825 7829
23. G. Ghilardi, M.L. Biondi, M. Caputo, S. Leviti, M. DeMonti, and E. Guagnellini A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility Clin. Cancer Res. 8 2002 3820 3823
24. G. Ghilardi, M.L. Biondi, M. Erario, E. Guagnellini, and R. Scorza Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms Clin. Chem. 49 2003 1940 1942
25. S. Matsumura, N. Oue, H. Nakayama, Y. Kitadai, K. Yoshida, and Y. Yamaguchi A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer J. Cancer Res. Clin. Oncol. 131 2005 19 25
26. Y. Kanamori, M. Matsushima, T. Minaguchi, K. Kobayashi, S. Sagae, and R. Kudo Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region Cancer Res. 59 1999 4225 4227
27. R.M. Wenham, B. Calingaert, S. Ali, K. McClean, R. Whitaker, and R. Bentley Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer J. Soc. Gynecol. Investig. 10 2003 381 387
28. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res. 16 1998 1215
29. B. Smolarz, K. Szyllo, H. Romanowicz-Makowska, M. Niewiadomski, E. Kozlowska, and A. Kulig PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer Pol. J. Pathol. 54 2003 233 238
30. K. Szyllo, B. Smolarz, H. Romanowicz-Makowska, M. Niewiadomski, E. Kozlowska, and A. Kulig The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer J. Exp. Clin. Cancer Res. 21 2002 357 361
31. G. Ghilardi, M.L. Biondi, M. Erario, E. Guagnellini, and R. Scorza Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms Clin. Chem. 49 2003 1940 1942
32. B. Quantin, G. Murphy, and R. Breathnach Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members Biochemistry 28 1989 5327 5334
33. V. Noe, B. Fingleton, K. Jacobs, H.C. Crawford, S. Vermeulen, and W. Steelant Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 J. Cell. Sci. 114 2001 111 118
34. H. Haro, H.C. Crawford, B. Fingleton, K. Shinomiya, D.M. Spengler, and L.M. Matrisian Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption J. Clin. Invest. 105 2000 143 150
35. W.C. Powell, B. Fingleton, C.L. Wilson, M. Boothby, and L.M. Matrisian The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis Curr. Biol. 9 1999 1441 1447
36. B.M. Gumbiner Cell adhesion: the molecular basis of tissue architecture and morphogenesis Cell. 84 1996 345 357
37. F. Carneiro, D.G. Huntsman, T.C. Smyrk, DA. Owen, R. Seruca, and P. Pharoah Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening J. Pathol. 203 2004 681 687
38. N. Pecina-SLaus, K. Gall-TroSelj, M. SLaus, K. Radic, T. NikuSeva-Martic, and K. Pavelic Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma Pathology 36 2004 145 151
39. W.C. Powell, B. Fingleton, C.L. Wilson, M. Boothby, and L.M. Matrisian The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis Curr. Biol. 9 1999 1441 1447
40. P. Schneider, N. Holler, J.L. Bodmer, M. Hahne, K. Frei, and A. Fontana Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity J. Exp. Med. 187 1998 1205 1213
41. V. Poulaki, C.S. Mitsiades, and N. Mitsiades The role of Fas and FasL as mediators of anticancer chemotherapy Drug Resist. Updat. 4 2001 233 242
42. F.H. Igney, and P.H. Krammer Death and anti-death: tumour resistance to apoptosis Nat. Rev., Cancer 2 2002 277 288
43. S. Barille, R. Bataille, M.J. Rapp, J.L. Harousseau, and M. Amiot Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation J. Immunol. 163 1999 5723 5728
44. H. Hirata, K. Naito, S. Yoshihiro, H. Matsuyama, Y. Suehiro, and Y. Hinoda A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma Int. J. Cancer 106 2003 372 374
45. Y. Zhu, M.R. Spitz, L. Lei, G.B. Mills, and X. Wu A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer the susceptibility Cancer Res. 61 2001 7825 7829
46. Y. Hinoda, N. Okayama, N. Takano, K. Fujimura, Y. Suehiro, and Y. Hamanaka Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer Int. J. Cancer 102 2002 526 529
47. G. Ghilardi, M.L. Biondi, M. Caputo, S. Leviti, M. DeMonti, and E. Guagnellini A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility Clin. Cancer Res. 8 2002 3820 3823
48. F. Grieu, W.Q. Li, and B. Iacopetta Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype Breast Cancer Res. Treat. 88 2004 197 204